Biocardia Stock Price History
BCDA Stock | USD 2.80 0.12 4.48% |
Below is the normalized historical share price chart for Biocardia extending back to November 13, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biocardia stands at 2.80, as last reported on the 29th of March, with the highest price reaching 2.95 and the lowest price hitting 2.58 during the day.
If you're considering investing in Biocardia Stock, it is important to understand the factors that can impact its price. Biocardia appears to be slightly risky, given 3 months investment horizon. Biocardia secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. By analyzing Biocardia's technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of Biocardia's Mean Deviation of 3.87, downside deviation of 4.44, and Risk Adjusted Performance of 0.1125 to double-check if our risk estimates are consistent with your expectations.
At present, Biocardia's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 169 M, whereas Total Stockholder Equity is forecasted to decline to about 795.1 K. . At present, Biocardia's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 7.50, whereas Price To Sales Ratio is forecasted to decline to 97.97. Biocardia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of March 2008 | 200 Day MA 2.5941 | 50 Day MA 2.4448 | Beta 1.279 |
Biocardia |
Sharpe Ratio = 0.1077
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | BCDA | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.16 actual daily | 46 54% of assets are more volatile |
Expected Return
0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Biocardia is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biocardia by adding it to a well-diversified portfolio.
Price Book 15.3357 | Enterprise Value Ebitda (3.16) | Price Sales 180.7885 | Shares Float 3.5 M | Wall Street Target Price 15.5 |
Biocardia Stock Price History Chart
There are several ways to analyze Biocardia Stock price data. The simplest method is using a basic Biocardia candlestick price chart, which shows Biocardia price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 14, 2025 | 2.84 |
Lowest Price | February 28, 2025 | 2.01 |
Biocardia March 29, 2025 Stock Price Synopsis
Various analyses of Biocardia's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biocardia Stock. It can be used to describe the percentage change in the price of Biocardia from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biocardia Stock.Biocardia Price Action Indicator | 0.09 | |
Biocardia Price Rate Of Daily Change | 1.04 | |
Biocardia Accumulation Distribution | 17,933 | |
Biocardia Price Daily Balance Of Power | 0.32 |
Biocardia March 29, 2025 Stock Price Analysis
Biocardia Stock Price History Data
The price series of Biocardia for the period between Sun, Dec 29, 2024 and Sat, Mar 29, 2025 has a statistical range of 0.87 with a coefficient of variation of 9.33. The prices are distributed with arithmetic mean of 2.39. The median price for the last 90 days is 2.41. The company had 1:15 stock split on 30th of May 2024. Biocardia issued dividends on 2019-06-06.Open | High | Low | Close | Volume | ||
03/28/2025 | 2.71 | 2.95 | 2.58 | 2.80 | 142,977 | |
03/27/2025 | 2.65 | 2.75 | 2.45 | 2.68 | 52,277 | |
03/26/2025 | 2.69 | 2.74 | 2.54 | 2.55 | 46,440 | |
03/25/2025 | 2.61 | 2.69 | 2.61 | 2.63 | 21,946 | |
03/24/2025 | 2.72 | 2.84 | 2.60 | 2.60 | 51,561 | |
03/21/2025 | 2.52 | 2.83 | 2.50 | 2.66 | 46,618 | |
03/20/2025 | 2.58 | 2.58 | 2.47 | 2.47 | 21,577 | |
03/19/2025 | 2.60 | 2.62 | 2.50 | 2.58 | 27,642 | |
03/18/2025 | 2.59 | 2.69 | 2.57 | 2.66 | 22,209 | |
03/17/2025 | 2.64 | 2.67 | 2.57 | 2.62 | 16,104 | |
03/14/2025 | 2.63 | 2.69 | 2.57 | 2.60 | 38,070 | |
03/13/2025 | 2.56 | 2.63 | 2.45 | 2.57 | 23,147 | |
03/12/2025 | 2.56 | 2.71 | 2.53 | 2.55 | 38,706 | |
03/11/2025 | 2.53 | 2.61 | 2.50 | 2.57 | 11,684 | |
03/10/2025 | 2.57 | 2.72 | 2.53 | 2.54 | 19,254 | |
03/07/2025 | 2.52 | 2.66 | 2.51 | 2.62 | 45,543 | |
03/06/2025 | 2.54 | 2.65 | 2.42 | 2.58 | 23,139 | |
03/05/2025 | 2.61 | 2.61 | 2.40 | 2.54 | 55,360 | |
03/04/2025 | 2.46 | 2.56 | 2.32 | 2.52 | 62,967 | |
03/03/2025 | 2.05 | 2.67 | 2.03 | 2.56 | 199,525 | |
02/28/2025 | 2.01 | 2.08 | 1.93 | 2.01 | 39,035 | |
02/27/2025 | 2.11 | 2.22 | 2.01 | 2.04 | 31,821 | |
02/26/2025 | 2.06 | 2.20 | 2.06 | 2.10 | 9,332 | |
02/25/2025 | 2.12 | 2.26 | 2.02 | 2.05 | 19,928 | |
02/24/2025 | 2.29 | 2.40 | 2.12 | 2.15 | 41,003 | |
02/21/2025 | 2.31 | 2.50 | 2.18 | 2.31 | 64,107 | |
02/20/2025 | 2.46 | 2.47 | 2.30 | 2.42 | 55,158 | |
02/19/2025 | 2.68 | 2.68 | 2.42 | 2.50 | 107,143 | |
02/18/2025 | 2.77 | 2.85 | 2.62 | 2.73 | 53,626 | |
02/14/2025 | 2.69 | 2.95 | 2.68 | 2.84 | 66,744 | |
02/13/2025 | 2.59 | 2.78 | 2.59 | 2.72 | 82,323 | |
02/12/2025 | 2.43 | 2.71 | 2.42 | 2.63 | 39,972 | |
02/11/2025 | 2.41 | 2.78 | 2.32 | 2.51 | 92,748 | |
02/10/2025 | 2.34 | 2.44 | 2.27 | 2.30 | 31,979 | |
02/07/2025 | 2.60 | 2.61 | 2.32 | 2.37 | 19,845 | |
02/06/2025 | 2.57 | 2.65 | 2.43 | 2.45 | 25,938 | |
02/05/2025 | 2.52 | 2.73 | 2.52 | 2.56 | 93,331 | |
02/04/2025 | 2.36 | 2.63 | 2.36 | 2.57 | 59,787 | |
02/03/2025 | 2.30 | 2.45 | 2.12 | 2.41 | 41,310 | |
01/31/2025 | 2.30 | 2.62 | 2.30 | 2.47 | 100,104 | |
01/30/2025 | 2.37 | 2.42 | 2.30 | 2.32 | 24,228 | |
01/29/2025 | 2.21 | 2.43 | 2.15 | 2.38 | 35,177 | |
01/28/2025 | 2.18 | 2.35 | 2.11 | 2.28 | 81,865 | |
01/27/2025 | 2.41 | 2.68 | 2.20 | 2.27 | 287,203 | |
01/24/2025 | 2.13 | 2.26 | 2.11 | 2.19 | 17,425 | |
01/23/2025 | 2.09 | 2.18 | 2.07 | 2.18 | 7,501 | |
01/22/2025 | 2.12 | 2.20 | 2.06 | 2.10 | 19,701 | |
01/21/2025 | 2.15 | 2.21 | 2.09 | 2.18 | 18,176 | |
01/17/2025 | 2.16 | 2.19 | 2.11 | 2.18 | 16,134 | |
01/16/2025 | 2.26 | 2.26 | 2.08 | 2.12 | 19,432 | |
01/15/2025 | 2.13 | 2.26 | 2.05 | 2.21 | 32,847 | |
01/14/2025 | 2.26 | 2.36 | 2.10 | 2.16 | 74,584 | |
01/13/2025 | 2.08 | 2.34 | 1.99 | 2.25 | 62,678 | |
01/10/2025 | 2.25 | 2.26 | 2.12 | 2.13 | 44,403 | |
01/08/2025 | 2.35 | 2.37 | 2.20 | 2.24 | 19,906 | |
01/07/2025 | 2.47 | 2.47 | 2.30 | 2.32 | 39,070 | |
01/06/2025 | 2.39 | 2.41 | 2.30 | 2.40 | 33,522 | |
01/03/2025 | 2.35 | 2.40 | 2.26 | 2.31 | 31,747 | |
01/02/2025 | 2.21 | 2.33 | 2.20 | 2.26 | 18,556 | |
12/31/2024 | 2.21 | 2.23 | 2.03 | 2.18 | 57,094 | |
12/30/2024 | 2.45 | 2.45 | 1.92 | 2.15 | 75,123 |
About Biocardia Stock history
Biocardia investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biocardia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biocardia will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biocardia stock prices may prove useful in developing a viable investing in Biocardia
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.7 B | 2.9 B | |
Net Loss | -10.7 M | -11.3 M |
Biocardia Stock Technical Analysis
Biocardia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
All Next | Launch Module |
Biocardia Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biocardia's price direction in advance. Along with the technical and fundamental analysis of Biocardia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biocardia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1125 | |||
Jensen Alpha | 0.664 | |||
Total Risk Alpha | 1.02 | |||
Sortino Ratio | 0.1629 | |||
Treynor Ratio | (5.89) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Biocardia Stock analysis
When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |